STOCK TITAN

[144] Phreesia, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Phreesia, Inc. Form 144 shows a proposed sale of 17,445 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $518,681.81, and an approximate sale date of 08/22/2025 on the NYSE. The filing lists the acquisition history for the shares sold, all noted as restricted stock vesting between April 2022 and April 2023, paid as compensation.

The form also discloses recent sales by insiders in the past three months, including multiple small sales by Jessica Weiss and larger sales by David Linetsky (notably 23,729 shares for $676,195.48 on 06/27/2025). The filer certifies no undisclosed material adverse information at signature.

Phreesia, Inc. Form 144 indica una proposta di vendita di 17.445 azioni ordinarie tramite Fidelity Brokerage Services per un valore complessivo di $518.681,81, con data approssimativa di vendita il 22/08/2025 sul NYSE. La comunicazione riporta la storia delle acquisizioni delle azioni cedute, tutte classificate come restricted stock vesting maturate tra aprile 2022 e aprile 2023 e corrisposte come compenso.

Il modulo segnala inoltre vendite recenti da parte di insider negli ultimi tre mesi, incluse diverse cessioni minori di Jessica Weiss e vendite più consistenti di David Linetsky (in particolare 23.729 azioni per $676.195,48 il 27/06/2025). Il firmatario dichiara l'assenza di informazioni materiali sfavorevoli non divulgate.

Phreesia, Inc. Form 144 muestra una propuesta de venta de 17,445 acciones ordinarias a través de Fidelity Brokerage Services por un valor agregado de $518,681.81, con fecha aproximada de venta el 22/08/2025 en la NYSE. La presentación detalla el historial de adquisición de las acciones vendidas, todas indicadas como restricted stock vesting entre abril de 2022 y abril de 2023, pagadas como compensación.

El formulario también revela ventas recientes de insiders en los últimos tres meses, incluidas múltiples ventas pequeñas de Jessica Weiss y ventas mayores de David Linetsky (notablemente 23,729 acciones por $676,195.48 el 27/06/2025). El declarante certifica que no existe información material adversa no divulgada al firmar.

Phreesia, Inc. Form 144은 Fidelity Brokerage Services를 통해 17,445 보통주를 총액 $518,681.81에 매도할 예정임을 나타내며, NYSE에서의 예상 매도일은 2025-08-22입니다. 제출서에는 매도된 주식들의 취득 내역이 기재되어 있으며, 모두 2022년 4월부터 2023년 4월 사이에 restricted stock vesting으로 취득되어 보수로 지급된 것으로 표시되어 있습니다.

해당 서식은 또한 지난 3개월간 내부자들의 최근 매도 내역을 공개하는데, Jessica Weiss의 소규모 다수 매도와 David Linetsky의 대규모 매도(특히 23,729주를 $676,195.48에 2025-06-27에 매도)가 포함됩니다. 서명자는 미공개된 중대한 불리한 정보가 없음을 인증합니다.

Phreesia, Inc. Form 144 indique une vente projetée de 17 445 actions ordinaires via Fidelity Brokerage Services pour une valeur totale de 518 681,81 $, avec une date approximative de vente le 22/08/2025 sur le NYSE. Le dépôt précise l'historique d'acquisition des actions vendues, toutes indiquées comme restricted stock vesting entre avril 2022 et avril 2023, versées en tant que rémunération.

Le formulaire divulgue également des ventes récentes d'initiés au cours des trois derniers mois, y compris plusieurs petites ventes de Jessica Weiss et des ventes plus importantes de David Linetsky (notamment 23 729 actions pour 676 195,48 $ le 27/06/2025). Le signataire certifie l'absence d'informations défavorables matérielles non divulguées.

Phreesia, Inc. Form 144 weist einen geplanten Verkauf von 17.445 Stammaktien über Fidelity Brokerage Services mit einem Gesamtwert von $518.681,81 aus, voraussichtliches Verkaufsdatum ist der 22.08.2025 an der NYSE. Die Meldung enthält die Erwerbshistorie der verkauften Aktien, die alle als restricted stock vesting zwischen April 2022 und April 2023 angegeben und als Vergütung gewährt wurden.

Das Formular legt zudem kürzliche Insiderverkäufe der letzten drei Monate offen, darunter mehrere kleinere Verkäufe von Jessica Weiss und größere Verkäufe von David Linetsky (insbesondere 23.729 Aktien für $676.195,48 am 27.06.2025). Der Unterzeichner bestätigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Rule 144 notice showing insider-originated restricted shares and recent insider sales; no forward-looking claims.

The filing documents a planned Rule 144 sale of 17,445 common shares valued at $518,681.81 to be executed via Fidelity on 08/22/2025. Acquisition dates are explicit and tied to restricted stock vesting events in 2022–2023, indicating the shares were compensation-based. The schedule of recent sales shows multiple transactions by named insiders, including a 23,729-share sale for $676,195.48 on 06/27/2025. From a market-impact perspective, the document is a disclosure of intent and past insider activity rather than an operational or financial update.

TL;DR: Formal insider sale notice with clear vesting provenance; disclosures align with Rule 144 procedural requirements.

The submission provides required information: broker, share counts, aggregate market value, acquisition method (restricted stock vesting), and prior three-month insider sales with gross proceeds. The signer affirms no undisclosed material adverse information. The document focuses on compliance and transparency around insider liquidity rather than signaling corporate governance changes or events.

Phreesia, Inc. Form 144 indica una proposta di vendita di 17.445 azioni ordinarie tramite Fidelity Brokerage Services per un valore complessivo di $518.681,81, con data approssimativa di vendita il 22/08/2025 sul NYSE. La comunicazione riporta la storia delle acquisizioni delle azioni cedute, tutte classificate come restricted stock vesting maturate tra aprile 2022 e aprile 2023 e corrisposte come compenso.

Il modulo segnala inoltre vendite recenti da parte di insider negli ultimi tre mesi, incluse diverse cessioni minori di Jessica Weiss e vendite più consistenti di David Linetsky (in particolare 23.729 azioni per $676.195,48 il 27/06/2025). Il firmatario dichiara l'assenza di informazioni materiali sfavorevoli non divulgate.

Phreesia, Inc. Form 144 muestra una propuesta de venta de 17,445 acciones ordinarias a través de Fidelity Brokerage Services por un valor agregado de $518,681.81, con fecha aproximada de venta el 22/08/2025 en la NYSE. La presentación detalla el historial de adquisición de las acciones vendidas, todas indicadas como restricted stock vesting entre abril de 2022 y abril de 2023, pagadas como compensación.

El formulario también revela ventas recientes de insiders en los últimos tres meses, incluidas múltiples ventas pequeñas de Jessica Weiss y ventas mayores de David Linetsky (notablemente 23,729 acciones por $676,195.48 el 27/06/2025). El declarante certifica que no existe información material adversa no divulgada al firmar.

Phreesia, Inc. Form 144은 Fidelity Brokerage Services를 통해 17,445 보통주를 총액 $518,681.81에 매도할 예정임을 나타내며, NYSE에서의 예상 매도일은 2025-08-22입니다. 제출서에는 매도된 주식들의 취득 내역이 기재되어 있으며, 모두 2022년 4월부터 2023년 4월 사이에 restricted stock vesting으로 취득되어 보수로 지급된 것으로 표시되어 있습니다.

해당 서식은 또한 지난 3개월간 내부자들의 최근 매도 내역을 공개하는데, Jessica Weiss의 소규모 다수 매도와 David Linetsky의 대규모 매도(특히 23,729주를 $676,195.48에 2025-06-27에 매도)가 포함됩니다. 서명자는 미공개된 중대한 불리한 정보가 없음을 인증합니다.

Phreesia, Inc. Form 144 indique une vente projetée de 17 445 actions ordinaires via Fidelity Brokerage Services pour une valeur totale de 518 681,81 $, avec une date approximative de vente le 22/08/2025 sur le NYSE. Le dépôt précise l'historique d'acquisition des actions vendues, toutes indiquées comme restricted stock vesting entre avril 2022 et avril 2023, versées en tant que rémunération.

Le formulaire divulgue également des ventes récentes d'initiés au cours des trois derniers mois, y compris plusieurs petites ventes de Jessica Weiss et des ventes plus importantes de David Linetsky (notamment 23 729 actions pour 676 195,48 $ le 27/06/2025). Le signataire certifie l'absence d'informations défavorables matérielles non divulguées.

Phreesia, Inc. Form 144 weist einen geplanten Verkauf von 17.445 Stammaktien über Fidelity Brokerage Services mit einem Gesamtwert von $518.681,81 aus, voraussichtliches Verkaufsdatum ist der 22.08.2025 an der NYSE. Die Meldung enthält die Erwerbshistorie der verkauften Aktien, die alle als restricted stock vesting zwischen April 2022 und April 2023 angegeben und als Vergütung gewährt wurden.

Das Formular legt zudem kürzliche Insiderverkäufe der letzten drei Monate offen, darunter mehrere kleinere Verkäufe von Jessica Weiss und größere Verkäufe von David Linetsky (insbesondere 23.729 Aktien für $676.195,48 am 27.06.2025). Der Unterzeichner bestätigt, dass keine nicht offengelegten, wesentlichen nachteiligen Informationen vorliegen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Phreesia

NYSE:PHR

PHR Rankings

PHR Latest News

PHR Latest SEC Filings

PHR Stock Data

1.65B
56.69M
4.33%
100.81%
4.88%
Health Information Services
Services-business Services, Nec
Link
United States
WILMINGTON